AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy for 2027?
Eli Lilly's revenue is climbing at a pace AbbVie can't match, yet AbbVie trades at a noticeably lower earnings multiple.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.